recombinant viral macrophage inflammatory protein (rvMIP) / Guangzhou Suyuan Biotech 
Welcome,         Profile    Billing    Logout  
  Diseases    Trials    Trials    News 
1 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
recombinant viral macrophage inflammatory protein (rvMIP) / Guangzhou Suyuan Biotech
ChiCTR2000029636: Efficacy and safety of aerosol inhalation of vMIP in the treatment of novel coronavirus pneumonia (COVID-19): a single arm clinical trial

Recruiting
N/A
40
China
Conventional standardized treatment and vMIP atomized inhalation
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology; Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Sponsored by Guangzhou Suyuan Biotechnology Co., Ltd
novel coronavirus pneumonia (COVID-19)
 
 

Download Options